| A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer JP Neoptolemos, DD Stocken, H Friess, C Bassi, JA Dunn, H Hickey, ... New England Journal of Medicine 350 (12), 1200-1210, 2004 | 3299 | 2004 |
| A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer JP Neoptolemos, DD Stocken, H Friess, C Bassi, JA Dunn, H Hickey, ... New England Journal of Medicine 350 (12), 1200-1210, 2004 | 3299 | 2004 |
| Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ... The Lancet 387 (10019), 679-690, 2016 | 1869 | 2016 |
| Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial JP Neoptolemos, DD Stocken, C Bassi, P Ghaneh, D Cunningham, ... Jama 304 (10), 1073-1081, 2010 | 1620 | 2010 |
| Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial JP Neoptolemos, JA Dunn, DD Stocken, J Almond, K Link, H Beger, ... The Lancet 358 (9293), 1576-1585, 2001 | 1349 | 2001 |
| Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial JP Neoptolemos, JA Dunn, DD Stocken, J Almond, K Link, H Beger, ... The Lancet 358 (9293), 1576-1585, 2001 | 1325 | 2001 |
| Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer D Cunningham, I Chau, DD Stocken, JW Valle, D Smith, W Steward, ... Journal of Clinical Oncology 27 (33), 5513-5518, 2009 | 1107* | 2009 |
| Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study JN Primrose, RP Fox, DH Palmer, HZ Malik, R Prasad, D Mirza, A Anthony, ... The Lancet Oncology 20 (5), 663-673, 2019 | 967 | 2019 |
| Clinical and genetic characteristics of hereditary pancreatitis in Europe N Howes, MM Lerch, W Greenhalf, DD Stocken, I Ellis, P Simon, ... Clinical Gastroenterology and Hepatology 2 (3), 252-261, 2004 | 761* | 2004 |
| Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial JP Neoptolemos, DD Stocken, JA Dunn, J Almond, HG Beger, P Pederzoli, ... Annals of surgery 234 (6), 758-768, 2001 | 721 | 2001 |
| Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the … RF Gabitass, NE Annels, DD Stocken, HA Pandha, GW Middleton Cancer Immunology, Immunotherapy 60, 1419-1430, 2011 | 675 | 2011 |
| Clinical and genetic characteristics of hereditary pancreatitis in Europe N Howes, MM Lerch, W Greenhalf, DD Stocken, I Ellis, P Simon, ... Clinical Gastroenterology and Hepatology 2 (3), 252-261, 2004 | 666 | 2004 |
| Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer DD Stocken, MW Büchler, C Dervenis, C Bassi, H Jeekel, JHG Klinkenbijl, ... British journal of cancer 92 (8), 1372-1381, 2005 | 501 | 2005 |
| Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study JW Valle, D Palmer, R Jackson, T Cox, JP Neoptolemos, P Ghaneh, ... Journal of clinical oncology 32 (6), 504-512, 2014 | 447 | 2014 |
| Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind … T Meyer, R Fox, YT Ma, PJ Ross, MW James, R Sturgess, C Stubbs, ... The lancet Gastroenterology & hepatology 2 (8), 565-575, 2017 | 438 | 2017 |
| Guidelines for the content of statistical analysis plans in clinical trials C Gamble, A Krishan, D Stocken, S Lewis, E Juszczak, C Doré, ... Jama 318 (23), 2337-2343, 2017 | 431 | 2017 |
| Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials G Butturini, DD Stocken, MN Wente, H Jeekel, JHG Klinkenbijl, ... Archives of surgery 143 (1), 75-83, 2008 | 354 | 2008 |
| Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2× 2 factorial randomized controlled trial comparing insulin pump with multiple daily … SA Little, L Leelarathna, E Walkinshaw, HK Tan, O Chapple, ... Diabetes care 37 (8), 2114-2122, 2014 | 290* | 2014 |
| A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin DH Palmer, DD Stocken, H Hewitt, CE Markham, AB Hassan, PJ Johnson, ... Annals of surgical oncology 14, 2088-2096, 2007 | 271 | 2007 |
| Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2× 2 factorial randomized controlled trial comparing insulin pump with multiple daily … SA Little, L Leelarathna, E Walkinshaw, HK Tan, O Chapple, ... Diabetes care 37 (8), 2114-2122, 2014 | 246 | 2014 |
